Chimeric peptides: A new approach to enhancing the immunogenicity of peptides with low MHC class I affinity application in antiviral vaccination

Journal of Immunology

Volumn 159, Issue 5, 1997, Pages 2391-2398

  Tourdot, Sophie ^a   Oukka, Mohamed ^a   Manuguerra, Jean Claude ^b   Magafa, Vassiliki ^c   Vergnon, Isabelle ^a   Riché, Nicole ^a   Bruley Rosset, Martine ^a   Cordopatis, Pavlos ^c   Kosmatopoulos, Konstadinos ^a  

^a INSERM   (France)

^b INSTITUT PASTEUR   (France)

^c UNIVERSITY OF PATRAS   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

ABC TRANSPORTER; CORE PROTEIN; HYBRID PROTEIN; INFLUENZA VACCINE; LYMPHOCYTE ANTIGEN RECEPTOR; NP PROTEIN; NUCLEOCAPSID PROTEIN; NUCLEOPROTEIN; PEPTIDE FRAGMENT; RECOMBINANT VACCINE; TAP1 PROTEIN, HUMAN; TAP1 PROTEIN, MOUSE; TAP2 PROTEIN, HUMAN; TAP2 PROTEIN, MOUSE; TUMOR PROTEIN; VIRUS VACCINE;

ANIMAL; ARTICLE; C57BL MOUSE; CELL CULTURE; CHEMISTRY; COMPARATIVE STUDY; CYTOTOXIC T LYMPHOCYTE; CYTOTOXICITY; GENETICS; IMMUNOLOGY; INFLUENZA VIRUS A; MALE; MOUSE; ORTHOMYXOVIRUS INFECTION; PATHOLOGY; PHYSIOLOGY; T CELL LYMPHOMA;

ANIMALS; ATP-BINDING CASSETTE TRANSPORTERS; CYTOTOXICITY, IMMUNOLOGIC; INFLUENZA A VIRUS; INFLUENZA VACCINES; LYMPHOMA, T-CELL; MALE; MICE; MICE, INBRED C57BL; NEOPLASM PROTEINS; NUCLEOCAPSID PROTEINS; NUCLEOPROTEINS; ORTHOMYXOVIRIDAE INFECTIONS; PEPTIDE FRAGMENTS; RECEPTORS, ANTIGEN, T-CELL; RECOMBINANT FUSION PROTEINS; T-LYMPHOCYTES, CYTOTOXIC; TUMOR CELLS, CULTURED; VACCINES, SYNTHETIC; VIRAL CORE PROTEINS; VIRAL VACCINES;

EID: 0031229803     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (12)

1. Aichele, P., H. Hergartner, R. M. Zinkernagel, and M. Schulz. 1990. Antiviral cytotoxic T cell response induced by in vitro priming with a free synthetic peptide. J. Exp. Med. 171:1815.
2. Schulz, M. R., M. Zinkernagel, and H. Hergartner. 1991. Peptide induced antiviral protection by cytotoxic T cells. Proc. Natl. Acad. Sci. USA 88:991.
3. Kast, M. W., L. Roux, J. Curren, H. J. J. Blom, A. C. Vooordouw, R. H. Melocn, D. Kolakofsky, and C. M. Melief. 1991. Protection against lethal Sendai virus infection by in vivo priming of virus specific cytotoxic T lymphocytes with a free synthetic peptide. Proc. Natl. Acad. Sci. USA 88:2283.
4. McNearney, T., Z. Hornicova, R. Markham, A. Birdwell, M. Arens, A. Saah, and L. Ratner. 1992. Relationship of human immunodeficiency virus type 1 sequence heterogeneity to stage of disease. Proc. Natl. Acad. Sci. USA 89:10247.
5. Wolinsky, S. M., B. T. M. Korber, A. U. Neumann, M. Daniel, K. J. Kunstman, A. J. Whetsel, M. R. Furtado, Y. Cao, D. D. Ho, J. T. Safrit, and R. A. Koup. 1996. Adaptive evolution of human immunodeficiency virus type 1 during the natural course of infection. Science 272:537.
6. Goulder, P. J. R., R. E. Philips, R. A. Colbert, S. McAdam, G. Ogg. M. A. Nowak, P. Giangrande, G. Luzzi, B. Morgan, A. Edwards, A. J. McMichael, and S. Rowland-Jones. 1997. Late escape from an immunodominant cytotoxic T lymphocyte response associated with progression to AIDS. Nat. Med. 3:212.
7. Borrow, P., H. Lewicki, X. Wei, M. S. Horowitz, N. Peffer, H. Meyers, J. A. Nelson, J. E. Gairin, B. H. Hahn, M. B. A. Oldstone, and G. M. Shaw. 1997. Antiviral pressure exerted by HIV-1-specific cytotoxic T lymphocytes (CTLs) during primary infection demonstrated by rapid selection of CTL escape variants. Nat. Med. 3:205.
8. Nowak, M. A., R. M. May, R. E. Phillips, S. Rowland-Jones, D. G. Calbo, S. McAdam, P. Klenerman, B. Köppe, K. Sigmunt, C. R. M. Bangham, and A. J. M. McMichael. 1995. Antigenic oscillations and shifting immunodominance in HIV-1 infections. Nature 375:606.
9. Koenig, S., A. J. Conley, Y. A. Brewal, G. M. Jones, S. Leath, L. J. Boots, V. Davey, G. Pantaleo, J. F. Demarest, C. Carter, C. Wannebo, J. R. Yannelli, S. A. Rosenberg, and H. C. Lane. 1995. Transfer of HIV-1 specific T lymphocytes to an AIDS patient leads to selection of mutant HIV variants and subsequent disease progression. Nat. Med. 1:330.
10. Coullin, I.. B. Culman-Panciolelli, E. Gomard, J. P. Levy, J. G. Guillet, and S. Saragosti. 1994. Impaired CTL recognition due to genetic variations in the main immunogenic region of the HIV-1 nef protein. J. Exp. Med. 180:1129.
11. Philips, R. E., S. Rowland-Jones, D. F. Nixon, F. M. Gotch, J. P. Edwards, A. O. Ogunlesi, J. G. Elvin, J. A. Rothbard, C. R. M. Bangham, C. R. Rizza, and A. J. McMichael. 1991. Human immunodeficiency virus genetic variations that can escape cytotoxic T cell recognition. Nature 354:453.
12. + population. Science 260:98.